Covid inquiry faces further delays after Lord Brailsford tumour diagnosis
Scotland’s Covid inquiry is set to face further delays after it was announced that chairman Lord Brailsford has been diagnosed with a kidney tumour.
Under the Inquiries Act 2005, public hearings cannot be held without the chair present, either in person or remotely. This means the timing of the inquiry’s next tranche of health and social care impact hearings will depend on when the surgery takes place and Lord Brailsford’s recovery period.
In a statement, the inquiry said that the 69-year-old was “continuing to work and is expected to make a full recovery following surgery”.
“The inquiry regrets any inconvenience the postponement of hearings may cause to witnesses, core participants and other interested parties but trusts they understand and will join us in extending our best wishes to Lord Brailsford for a full and speedy recovery,” the statement said.
Previous chairman, Lady Poole, resigned in October 2022 for personal reasons. The inquiry statement added that work was continuing despite the pause in hearings.
“The inquiry is continuing its investigations and will shortly publish academic research and embark on the focused engagement period of its listening project, Let’s Be Heard,” it said.
“In addition, Lord Brailsford will be reviewing applications for core participant status from those with an interest in the inquiry’s Term of Reference 2(k), education and certification, and the inquiry’s legal team will continue to gather and analyse evidence.”